Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2025 Jun 17.
Published in final edited form as: AIDS Behav. 2025 Feb 13;29(5):1692–1703. doi: 10.1007/s10461-024-04609-3

PrEP Awareness and Coverage: Results from the 2022 South Africa Antenatal HIV Sentinel Survey

Nosipho Shangase 1, Tendesayi Kufa 1,2, Mireille Cheyip 3, Adrian Puren 1,4
PMCID: PMC12171419  NIHMSID: NIHMS2066996  PMID: 39939480

Abstract

Pregnant women have a high HIV incidence in South Africa (SA), increasing the risk of mother-to-child transmission (MTCT) of HIV. Strengthening coverage of HIV prevention strategies such as pre-exposure prophylaxis (PrEP) is essential to ending the epidemic in SA. We estimated awareness and coverage of PrEP among pregnant women attending antenatal clinics. Using the national cross-sectional antenatal HIV sentinel survey SA, that was conducted from February to April 2022, we performed descriptive and survey logistic regression analyses. Women were deemed as aware about PrEP if they reported ever having heard of PrEP. Women were eligible for PrEP if they were HIV-negative and had either: (1) an HIV-positive/status-unknown partner; (2) multiple sexual partners in the past twelve months; (3) a sexually transmitted infection in the preceding six months; or (4) sex under the influence of alcohol/drugs in the past six months. 31.18% (n = 7 271) of HIV-negative women were eligible for PrEP. Among eligible women, 33.65% (n = 2 403) were aware about PrEP, 3.58% (n = 271) took PrEP before pregnancy, and 6.50% (n = 507) were currently on PrEP. Compared to follow-up visit attendees, first ANC visit attendees were less likely to be: (1) aware about PrEP (adjusted odds ratio (aOR) = 0.65; 95% confidence interval (CI): 0.59–0.72), and (2) to currently be on PrEP (aOR = 0.69; 95% CI: 0.57–0.84). Women who had never tested for HIV before pregnancy were less likely to: (1) be aware about PrEP (aOR = 0.51; 95% CI: 0.45–0.59), and (2) currently be on PrEP (aOR = 0.56; 95% CI: 0.43–0.74) compared to those who had tested for HIV before pregnancy. Women who reported having an HIV-positive partner compared to those with an HIV-negative partner had higher: (1) PrEP awareness (aOR = 2.21; 95% CI: 1.80–2.71), and (2) PrEP coverage during pregnancy (aOR = 8.51; 95% CI: 6.43–11.25). Overall PrEP awareness and coverage were low. PrEP is being integrated into safe conception programs as an HIV prevention strategy. Entry into ANC presents an important opportunity to prevent new HIV infections among new mothers, accelerating the elimination of MTCT of HIV in the country.

Keywords: PrEP, Pregnant women, South Africa, Antenatal care

Introduction

South Africa (SA) continues to be at the epicentre of the HIV epidemic, with an estimated 7.6 million people living with HIV (PLHIV) in 2022 [1]. Among PLHIV in SA, women (≥ 15 years) are disproportionately affected by HIV, accounting for 63% of PLHIV while men (≥ 15 years) only account for 34% of PLHIV [1]. Moreover, the 2022 National Antenatal HIV Sentinel Survey estimated that the national HIV prevalence was 27.5% among pregnant women (15–49 years) attending antenatal care (ANC) [2]. In addition to the high HIV prevalence among women, the HIV incidence in women is also higher than in men. Out of the 160 000 new HIV infections that occurred in the country in 2022, 100 000 new infections were among women aged ≥ 15 years while only 52 000 new infections were among men in the same age group [1]. Among pregnant women, the HIV incidence was estimated to be 1.5% in the 2017 SA National Antenatal HIV Sentinel Survey [3].

Over the years, in South Africa antiretroviral therapy (ART) treatment as prevention has helped reduce HIV incidence, along with condom promotion and voluntary medical male circumcision [4]. To prevent new HIV infections, a combination prevention approach remains essential. Thus, the strengthening of coverage of pre-exposure prophylaxis (PrEP) for people with an HIV-negative status has been a game-changer for ending the epidemic [5]. PrEP prevents HIV acquisition by providing antiretroviral drugs to people who are HIV-negative before potential HIV exposure [6, 7]. In 2015, the WHO expanded PrEP recommendations to all people at substantial risk of HIV due to the effectiveness of PrEP in preventing HIV acquisition [6]. The shift in the WHO PrEP recommendations was informed by evidence from trials demonstrating the effectiveness of PrEP in preventing HIV infection [6]. Shortly after SA began to supply PrEP in 2016 [8], the WHO expanded PrEP recommendations to include pregnant and breastfeeding women as a means to prevent mother-to-child transmission (MTCT) of HIV [9]. In SA, PrEP has been integrated into existing health services, including ANC, for pregnant women at substantial risk for HIV [10]. However, only in the 2023 PMTCT guidelines is PrEP recommended as an HIV prevention intervention for HIV-negative pregnant and breast-feeding women [11].

In terms of PrEP coverage in South Africa, it was estimated to be < 1% [12] with over 1 million PrEP initiations towards the end of 2024 [13]. Research in South Africa supports that PrEP uptake reduces HIV incidence [14]. Common barriers to PrEP use in South Africa include long wait times at facility [15, 16], lack of knowledge about PrEP [1719], and concerns about safety among pregnant women [20, 21]. In the 2023–2028 National Strategic Plan for HIV, TB and STIs for South Africa, increasing access and coverage of HIV prevention services, including PrEP, among pregnant women is one of the key strategies to accelerate the country’s goal to eliminate MTCT of HIV [22]. Thus, in alignment with the country’s goal, we examined PrEP awareness and coverage among pregnant women participating in the 2022 National Antenatal HIV Sentinel Survey to better understand PrEP coverage among pregnant women in SA.

Methods

The national Antenatal HIV Sentinel survey is a cross-sectional survey conducted every two years across all 52 districts in the nine South African provinces. The 2022 edition of the survey was conducted in 1 595 public health facilities which were selected using a stratified cluster sampling method. The probability proportional to size method was used to select sites within each district. The survey was conducted among pregnant women between 15 and 49 years of age attending ANC either for the first time or for a follow-up visit in the sampled facilities. This study excluded pregnant women who previously visited the clinic during the survey data collection period and those who were < 15 or > 49 years. A study barcode sticker was placed on the medical record of each survey participant to indicate their survey participation. The barcode was then used to identify and exclude women who already participated in the survey. Detailed methods have been previously described [23].

The 2022 survey was conducted from February to April 2022 and included 37 828 pregnant women. Health workers or antenatal nurses collected data as they provided routine ANC services. Data collection consisted of a brief interview, medical records data abstraction and blood specimen collection from consenting eligible pregnant women. The following were extracted from medical records: women’s age, ANC visit number (could range from 1 to 8 visits based on national guidelines [24]), HIV testing, trimester at 1st ANC, and syphilis test results (these were positive or negative as determined and documented by a provider). For syphilis testing, the National Department of Health (NDoH) Sexually Transmitted Infections (STIs) Management Guidelines recommend using a Rapid Plasmin Reagin test along with a specific treponemal test [25]. Data were also collected by self-report which included the participant’s ethnicity, education, marital status, parity, HIV testing before pregnancy, number of sexual partners, HIV status of the partner, and prior and current PrEP coverage.

Data Analysis

For this analysis, the primary outcomes included: (1) PrEP awareness, (2) PrEP coverage before current pregnancy, and (3) PrEP coverage during their current pregnancy. Women were considered to be eligible for PrEP if they were HIV-negative (based on medical record review) and had either: (1) an HIV-positive/status-unknown partner; (2) multiple sexual partners (defined as > 1 sexual partner) in the past twelve months; (3) a self-reported STI in the preceding six months (yes/no); or (4) sex under the influence of alcohol or drugs in the past six months. The eligibility criteria were based on the NDoH guidelines for PrEP provision [7]. PrEP awareness was defined as the proportion of those who responded with a “yes” when asked, “have you ever heard of PrEP before today?” PrEP coverage before the current pregnancy was defined as the proportion of those who were PrEP eligible and reported having been taking PrEP before this pregnancy. Current PrEP coverage was defined as the proportion of those pregnant women who were eligible for PrEP and responded with a “yes” when asked “are you currently taking PrEP?” It is possible for a participant to be aware about PrEP, have used PrEP before current pregnancy and use PrEP during the current pregnancy.

We performed analyses using STATA 17 (StataCorp. 2021. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC). The analysis accounted for survey design (clustering within facilities and stratification by district) and was weighted using the Statistics South Africa 2021 mid-year population size of women of reproductive age (15–49 years) at the provincial level. We conducted a complete-case analysis. We performed descriptive and survey logistic regression analyses. Crude and multivariable logistic models were used to assess factors associated with outcomes of interest (PrEP awareness and coverage). The multivariable models were adjusted for age, education, gravidity and province, which were selected based on a review of prior literature [2630]. We reported odds ratios (OR), adjusted odds ratio (AOR), and 95% confidence intervals (CIs).

Ethical Considerations

Survey participation was voluntary. Written informed consent was obtained from participants at enrolment. Ethical approval was obtained from the University of the Witwatersrand Human Research Ethics Committee (Medical) (M170556) and also from the nine provincial health research ethics committee. This activity was reviewed by CDC, deemed not research, and was conducted consistent with applicable federal law and CDC policy.§1

Results

A total of 37,828 women were enrolled in the 2022 antenatal survey, of which 22 655 (60.20%) had HIV-negative test results based on medical records (Table 1). Among the HIV-negative women, 7 271 (31.18%) were eligible for PrEP while 68.82% (n = 15 384) were ineligible for PrEP.

Table 1.

Characteristics of HIV-Negative, PrEP Eligible and PrEP Ineligible Pregnant Women Enrolled in the 2022 ANC Sentinel Survey, South Africa (N = 22 655)


Total HIV Negative
HIV negative PrEP Eligible
HIV negative PrEP Ineligible
Characteristics
n
%
n
%
n
%
Total 22655 60.20 7271 31.18 15384 68.82
Age (years)
 15–24 10718 45.89 3761 50.24 6957 43.92
 25–29 5947 26.78 1767 24.65 4180 27.74
 30–34 3721 17.12 1077 15.55 2644 17.83
 35–39 1823 8.25 534 7.64 1289 8.52
 40–44 422 1.86 127 1.85 295 1.87
 45–49 24 0.10 5 0.06 19 0.11
Education
 None 143 0.66 60 0.90 83 0.56
 Primary Schooling 1943 8.82 764 10.93 1179 7.86
 Secondary Schooling 16420 71.57 5291 71.82 11129 71.45
 Tertiary Schooling 3776 17.33 1052 14.93 2724 18.43
 Missing 373 1.62 104 1.43 269 1.70
Ethnicity
 African 19185 85.39 6279 86.99 12906 84.67
 Asian 200 0.91 48 0.75 152 0.98
 Coloured 2599 10.70 792 10.15 1807 10.95
 White 426 1.86 107 1.41 319 2.07
 Other 178 0.85 30 0.47 148 1.02
 Missing 67 0.29 15 0.24 52 0.31
ANC visit
 First 6759 31.49 2345 33.96 4414 30.37
 Second 4021 17.05 1307 17.25 2714 16.95
 Third 3884 16.66 1205 15.82 2679 17.04
 Fourth 7492 32.53 2265 30.86 5227 33.28
 Missing 499 2.28 149 2.10 350 2.36
Received an HIV test before pregnancy
 Yes 17744 78.87 5561 76.90 12183 79.76
 No 4256 18.45 1561 21.15 2695 17.23
 Missing 655 2.68 149 1.95 506 3.01
Relationship with the father of the baby
 Married 3631 16.90 806 11.67 2825 19.26
 Living together/cohabiting 5438 25.97 1648 24.91 3790 26.46
 Not living together but in a relationship 12626 52.92 4412 57.80 8214 50.70
 No relationship 814 3.53 365 5.03 449 2.85
 Missing 146 0.68 40 0.58 106 0.73
Number of sexual partners in the past 12 months
 More than one 1009 4.39 1009 14.06 0 0.00
 One sexual partner 18894 82.78 6092 83.53 12802 82.44
 Missing 2752 12.83 170 2.40 2582 17.52
HIV Status of Partner
 Positive 299 1.25 299 4.00 0 0.00
 Unknown 4976 21.36 4976 68.23 0 0.00
 Negative 11972 53.74 1547 22.04 10425 68.19
 Missing 5227 23.65 416 5.73 4811 31.81
Syphilis Status
 Positive 462 2.51 462 5.94 0 0.00
 Negative 16906 97.49 5079 67.24 11827 74.07
 Missing 5287 26.20 1730 26.82 3557 25.93

Of the 7 271 women eligible for PrEP, the median age was 24 years (interquartile range (IQR): 20–30) and 50.24% (n = 3 761) were aged 15–24 years. Majority of the participants had up to a secondary level education (71.82%, n = 5 291), and were of African/black ethnicity (86.99%, n = 6 279). Over one-third of women were first time ANC visit attendees (33.96%, n = 2 345) while 30.86% (n = 2 265) were fourth-ANC visit attendees. HIV testing before the current pregnancy was common (76.90%, n = 5 561). More than half of the women were not cohabiting but in a relationship with the father of the baby (57.80%, n = 4 412). The majority (83.53%, n = 6 092) of participants reported having one sexual partner in the past twelve months. Among eligible women, 4.00% (n = 299) reported having an HIV-positive sexual partner and 68.23% (n = 4 976) reported not knowing their sexual partner’s HIV status. Overall, 5.94% (n = 462) of all participants were positive for syphilis.

PrEP Awareness

Of the 7 271 PrEP eligible women, 33.65% (n = 2 403) were aware of PrEP (Table 2). Among PrEP eligible women who were PrEP aware, 49.48% (n = 1 219) were aged 15–24 years, 71.43% (n = 1 724) reported having up to a secondary education, and 95.68% (n = 2 297) were of African or black ethnicity. Just over one third (34.09%, n = 814) were attending ANC for a fourth visit, 83.04% (n = 1 991) reported having received an HIV test before pregnancy, and 63.97% (n = 1 612) were in a relationship but not cohabiting with the father of the baby. Most reported having one sexual partner (84.21%, n = 2 023) in the past twelve months, and having a partner with an unknown HIV status (61.33%, n = 1 475). Among participants aware of PrEP, 5.55% (n = 143) had a documented positive syphilis test result.

Table 2.

PrEP Awareness and PrEP Coverage among eligible pregnant women enrolled in the 2022 ANC Sentinel Survey, South Africa (N = 7 271)

Characteristics PrEP Awareness (N = 6888)
PrEP Use Before (N = 7133)
Current PrEP Use (N = 7122)
n % n % n %
Total 2403 33.65 271 3.58 507 6.50
Age (years)
 15–24 1219 49.48 124 45.98 279 53.30
 25–29 609 25.24 75 25.69 109 22.01
 30–34 381 16.94 44 17.55 73 15.05
 35–39 154 6.55 22 8.31 33 7.03
 40–44 38 1.70 6 2.47 13 2.61
 45–49 2 0.10 0 0.00 0 0.00
Education
 None 13 0.51 1 0.35 2 0.37
 Primary schooling 167 7.11 11 5.32 43 8.63
 Secondary schooling 1724 71.43 209 78.05 391 77.33
 Tertiary schooling 470 19.66 45 16.19 61 11.96
 Missing 29 1.28 5 1.44 10 1.71
Ethnicity
African 2297 95.68 270 99.71 498 98.29
 Asian 11 0.53 0 0 2 0.33
 Coloured 70 2.73 1 0.29 3 0.39
 White 17 0.68 0 0.00 1 0.20
 Other 1 0.04 0 0.00 0 0.00
 Missing 7 0.35 0 0.00 3 0.80
ANC visit
 First 652 28.64 82 32.62 128 27.04
 Second 482 19.46 46 18.03 114 21.43
 Third 421 16.32 53 18.02 101 19.53
 Fourth 814 34.09 87 30.44 156 29.79
 Missing 34 1.49 3 0.90 8 2.20
Received an HIV test before pregnancy
 Yes 1991 83.04 243 90.52 412 82.64
 No 350 14.48 19 6.23 75 13.82
 Missing 62 2.49 9 2.86 20 3.54
Relationship with the father of the baby
 Married 203 8.60 15 5.63 32 6.64
 Living together/co-habiting 463 21.81 61 24.20 100 21.40
 Not living together but in a relationship 1612 63.97 180 64.06 356 67.84
 No relationship 106 4.76 13 5.56 13 2.54
 Missing 19 0.87 2 0.55 6 1.54
Number of sexual partners in the past 12 months
 More than one 341 14.01 55 20.82 56 11.42
 One sexual partner 2023 84.21 209 76.39 440 86.40
 Missing 39 1.79 7 2.79 11 2.18
HIV Status of Partner
 Positive 170 7.12 68 26.35 97 20.49
 Unknown 1475 61.33 109 38.28 288 55.40
 Negative 606 25.93 74 28.89 96 19.56
 Missing 138 5.62 19 6.48 23 4.55
Syphilis Status
 Positive 143 5.55 19 6.57 39 7.54
 Negative 1774 71.21 188 65.58 362 69.45
 Missing 486 23.24 64 27.85 106 23.00

In the adjusted logistic model (Table 3), PrEP eligible women with a tertiary level education had a greater likelihood of having PrEP awareness (adjusted odds ratio (aOR) = 1.66, 95% CI: 1.46–1.89). Women who were of African or black ethnicity were more likely to be PrEP aware than those of other ethnicities (aOR = 3.41, 95% CI: 2.79–4.16). First-ANC visit attendees were less likely to be PrEP aware compared to those with follow-up ANC attendees (aOR = 0.65, 95% CI: 0.59–0.72). Those who had never tested for HIV before pregnancy were less likely to have PrEP awareness compared to those who reported having HIV testing before pregnancy (aOR = 0.51, 95% CI: 0.45–0.59). The likelihood of PrEP awareness was lower among married or cohabiting women compared to those not cohabiting or in a relationship with the father of the baby (aOR = 0.65, 95% CI: 0.59–0.73). Compared to women who had a HIV-negative partner, women who had an HIV-positive partner were more likely to be PrEP aware (aOR = 2.21, 95% CI: 1.80–2.71). Additionally, women with a status unknown partner were less likely to be PrEP aware compared to women who had a HIV-negative partner (aOR = 0.70, 95% CI: 0.63–0.79). PrEP awareness was more likely among women who attended their first ANC booking in the first trimester (aOR = 1.38, 95% CI: 1.11–1.73) and second trimester (aOR = 1.28, 95% CI: 1.05–1.57) compared to women who attended their first ANC booking in the third trimester.

Table 3.

Factors Associated with PrEP Awareness among Pregnant PrEP Eligible Women Enrolled in the 2022 ANC Sentinel Survey, South Africa (N = 7 271)

Factor % OR 95% CI OR 95% CI
Age (years)
 15–24 33.08 0.95 0.88 1.03 0.95 0.86 1.06
 25–49 34.23 1 - 1 -
Education
 <=Secondary Schooling 31.81 1 - 1 -
 Tertiary schooling 44.29 1.70 1.50 1.93 1.66 1.46 1.89
Ethnicity
 African 36.94 4.94 4.10 5.95 3.41 2.79 4.16
 Other 10.60 1 - 1 -
First ANC visit
 Yes 28.45 0.69 0.62 0.76 0.65 0.59 0.72
 No 36.70 1 - 1 -
HIV testing before pregnancy
 Never 23.13 0.53 0.47 0.60 0.51 0.45 0.59
 Yes 36.22 1 - 1 -
Relationship with father of the baby
 Married/Living together/co-habiting 28.14 0.68 0.62 0.74 0.65 0.59 0.73
 Not living together but in a relationship/no relationship 36.67 1 - 1 -
Multiple sexual partners
 Yes 34.05 1.02 0.88 1.18 1.00 0.86 1.16
 No 33.56 1 - 1 -
HIV Status of Partner
 Positive 57.96 2.21 1.81 2.70 2.21 1.80 2.71
 Unknown 29.91 0.68 0.61 0.76 0.70 0.63 0.79
 Negative 38.41 1 - 1 -
Syphilis result
 Positive 35.27 0.97 0.80 1.17 1.03 0.85 1.26
 Negative 35.97 1 - 1 -
Parity
 None 33.77 1.01 0.94 1.10 0.99 0.87 1.13
 ≥ 2 33.45 1 - 1 -
Trimester at 1st ANC Visit
 1 33.83 1.29 1.04 1.59 1.38 1.11 1.73
 2 33.69 1.28 1.05 1.55 1.28 1.05 1.57
 3 28.44 1 - 1 -

PrEP Coverage Before Pregnancy

Of the PrEP eligible women (n = 7 271), 3.58% (n = 271) reported taking PrEP before their pregnancy (Table 2). Women taking PrEP before pregnancy were primarily aged 15–24 years (n = 124, 45.98%), had up to a secondary education (n = 209, 78.05%), and were of African or black ethnicity (n = 270, 99.71%). About one-third were first-ANC visit attendees (32.62%, n = 82), 90.52% (n = 243) had tested for HIV prior to pregnancy, and most women were not cohabiting but in a relationship with the father of the baby (n = 180, 64.06%). Majority of the women reported having had one sexual partner in the past twelve months (76.39%, n = 209). In addition, 38.28% of respondents reported having a partner with an unknown HIV status (n = 109) and 6.57% (n = 19) of the participants had a positive test result for syphilis.

From the adjusted model (Table 4), women of African or black ethnicity more likely to use PrEP prior to pregnancy than women of another ethnicity (aOR = 38.27; 95% CI: 7.24–202.32). The likelihood of PrEP coverage prior to pregnancy was lower among participants who had never tested for HIV prior pregnancy (aOR = 0.24, 95% CI: 0.15–0.36) and for those married or cohabiting with the father of the baby (aOR = 0.65, 95% CI: 0.51–0.85). Women who had multiple partners in the past twelve months were more likely to be on PrEP prior to pregnancy (aOR = 1.69, 95% CI: 1.32–2.17). Participants with a HIV-positive partner were more likely to be on PrEP prior to pregnancy (aOR = 6.45, 95% CI: 4.81–8.66), and those with a status unknown partner were less likely to be on PrEP prior to pregnancy (aOR = 0.41, 95% CI: 0.32–0.53).

Table 4.

Factors associated with prior PrEP Coverage among pregnant PrEP Eligible Women enrolled in the 2022 ANC Sentinel Survey, South Africa (N = 7 271)

Factor % Crude
Adjusted
OR 95% CI OR 95% CI
Age (years)
 15–24 3.28 0.83 0.68 1.02 0.84 0.65 1.09
 25–49 3.90 1.00 - 1.00 -
Education
 <=Secondary schooling 3.54 1.00 - 1.00 -
 Tertiary schooling 3.83 1.09 0.84 1.41 1.06 0.81 1.38
Ethnicity
 African 4.10 51.62 9.94 268.01 38.27 7.24 202.32
 Other 0.08 1.00 - 1.00 -
First ANC visit
 Yes 3.43 0.92 0.73 1.15 0.91 0.73 1.15
 No 3.73 1.00 - 1.00 -
HIV testing before pregnancy
 Never 1.05 0.24 0.16 0.36 0.24 0.15 0.36
 Yes 4.23 1.00 - 1.00 -
Relationship with father of the baby
 Married/Living together/cohabiting 2.94 0.74 0.59 0.92 0.65 0.51 0.85
 Not living together but in a relationship/no relationship 3.96 1.00 - 1.00 -
Multiple sexual partners
 Yes 5.31 1.67 1.30 2.13 1.69 1.32 2.17
 No 3.25 1.00 - 1.00 -
HIV Status of Partner
 Positive 23.58 6.34 4.78 8.41 6.45 4.81 8.66
 Unknown 2.00 0.42 0.33 0.53 0.41 0.32 0.53
 Negative 4.64 1.00 - 1.00 -
Syphilis result
 Positive 4.43 1.29 0.85 1.97 1.34 0.88 2.05
 Negative 3.47 1.00 - 1.00 -
Parity
 None 3.42 0.91 0.74 1.10 1.02 0.72 1.45
 ≥ 2 3.76 1 - 1 -
Trimester at 1st ANC Visit
 1 4.27 1.38 0.84 2.27 1.42 0.86 2.36
 2 3.32 1.06 0.66 1.72 1.02 0.63 1.67
 3 3.13 1 - 1 -

PrEP Coverage During Current Pregnancy

From the women who were eligible for PrEP (n = 7 271), only 6.50% (n = 507) were on PrEP during their current pregnancy (Table 2). The majority of participants currently on PrEP were aged 15–24 years (53.30%, n = 279), completed a secondary level education (77.33%, n = 391) and were of African or black ethnicity (98.29%, n = 498). Nearly one-third of the women were attending their fourth ANC visit (29.79%, n = 156), more than 80% reported having had HIV testing prior to pregnancy (82.64%, n = 412), and 67.84% (n = 356) were not cohabiting but in a relationship with the father of the baby. Most participants reported having one sexual partner (86.40%, n = 440), and having a partner with an unknown HIV status (55.40%, n = 288). From those currently on PrEP, 7.54% (n = 39) tested positive for syphilis.

Multivariable modelling (Table 5) showed, PrEP eligible women of African or black ethnicity had a greater likelihood of PrEP coverage during their current pregnancy (aOR = 15.32, 95% CI: 7.42–31.63). Those utilizing ANC for the first time (aOR = 0.69, 95% CI: 0.57–0.84) and those who reported never having had HIV testing before pregnancy (aOR = 0.56, 95% CI: 0.43–0.74) were less likely to be currently taking PrEP. The likelihood of PrEP coverage during current pregnancy was lower among married or cohabiting women (aOR = 0.63, 95% CI: 0.51–0.77). Women with a HIV-positive partner were 8.51 (95% CI: 6.43–11.25) times more likely to use PrEP during their current pregnancy compared to women with a HIV-negative partner. Moreover, those who tested positive for syphilis (aOR = 1.46, 95% CI: 1.07–2.00) were more likely to use PrEP during their current pregnancy.

Table 5.

Factors associated with current PrEP Coverage among pregnant PrEP Eligible Women enrolled in the 2022 ANC Sentinel Survey, South Africa (N = 7 271)

Factor % Crude
Adjusted
OR 95% CI OR 95% CI
Age (years)
 15–24 6.87 1.13 0.98 1.31 1.23 1.01 1.50
 25–49 6.12 1.00 - 1.00 -
Education
 <=Secondary schooling 6.70 1.00 - 1.00 -
 Tertiary schooling 5.24 0.77 0.61 0.98 0.79 0.62 1.01
Ethnicity
 African 7.33 16.58 8.24 33.39 15.32 7.42 31.63
 Other 0.47 1.00 - 1.00 -
First ANC visit
 Yes 5.17 0.70 0.58 0.85 0.69 0.57 0.84
 No 7.20 1.00 - 1.00 -
HIV testing before pregnancy
 Never 7.00 0.58 0.45 0.75 0.56 0.43 0.74
 Yes 4.21 1.00 - 1.00 -
Relationship with father of the baby
 Married/Living together/cohabiting 7.26 0.67 0.56 0.82 0.63 0.51 0.77
 Not living together but in a relationship/no relationship 5.02 1.00 - 1.00 -
Multiple sexual partners
 Yes 5.26 0.78 0.60 1.00 0.76 0.58 0.99
 No 6.68 1.00 - 1.00 -
HIV Status of Partner
 Positive 33.26 8.21 6.27 10.76 8.51 6.43 11.25
 Unknown 5.23 0.91 0.73 1.13 0.87 0.70 1.08
 Negative 5.72 1.00 - 1.00 -
Syphilis result
 Positive 9.18 1.42 1.05 1.92 1.46 1.07 2.00
 Negative 6.66 1.00 - 1.00 -
Parity
 None 6.47 1.00 0.87 1.14 1.01 0.81 1.26
 ≥ 1 6.50 1 - 1 -
Trimester at 1st ANC visit
 1 6.84 1.30 0.89 1.92 1.37 0.93 2.02
 2 6.42 1.22 0.85 1.75 1.21 0.84 1.74
 3 5.33 1 - 1 -

Discussion

In this study, we examined PrEP awareness and PrEP coverage among pregnant women attending ANC clinics in SA. We found, 31.12% of HIV-negative pregnant women attending public health facilities in SA had substantial risk of acquiring HIV, and were thus, eligible for PrEP. However, only 33.65% of women with substantial risk of HIV were PrEP aware, with 3.58% having taken PrEP before pregnancy, and 6.50% currently on PrEP.

In terms of the low PrEP awareness found in this study, similarly, a study conducted in 2016 among pregnant and postpartum women in Cape Town found that 33.00% of the participants were aware about PrEP [31]. However, in another PrEP study conducted in Durban from 2018 to 2019, only 9.10% of the women had heard about PrEP prior to study enrolment [32]. A systematic review on HIV PrEP in Sub-Saharan Africa showed that PrEP awareness ranged from 23–98% [33]. Our findings revealed that PrEP awareness was associated with education level, specifically those who had a higher-level education (tertiary) were more likely to be PrEP aware compared to those with a secondary level education or less. Similar to our findings, a study conducted in SA revealed that PrEP awareness was higher among university students (9.80%) than primary health care clinic attendees (2.50%) [34]. In addition, a population-based survey analysis on women in 5 Sub-Saharan African countries revealed that those with a primary or secondary/higher education (compared to no education) were more likely to be aware about PrEP [35].

Study findings revealed, PrEP awareness was lower among those were first-ANC visit attendees, and among those who reported never having had HIV testing before their current pregnancy. Prior research has shown a lack of awareness that PrEP is available in public health facilities [34]. Similarly, a study among women in Sub-Saharan Africa revealed that those with a least one ANC follow-up had higher PrEP awareness [35]. Furthermore, women who do not utilize ANC tend to not have access to healthcare, specifically access to HIV testing services or HIV prevention services and therefore might be unaware of PrEP availability until entry into ANC. Our findings also highlight the importance of ANC as a health education platform and the need to make health information available through other channels for non-pregnant women. Moreover, we found that PrEP awareness was lower among those who were married or cohabiting with the father of their baby. Married or cohabiting women might not perceive themselves as being at risk of acquiring HIV and/or may not engage in HIV-related risk behaviours. Risk perception plays a substantial role in the use of HIV prevention services, including PrEP [36].

We showed that PrEP awareness and PrEP coverage (prior and current) were higher among those with a HIV-positive partner, which aligns with PrEP guidelines [10]. The two most common reasons for PrEP initiation among women of reproductive age in Kenya were having a sexual partner of either known HIV-positive status or unknown HIV status [37]. A Sub-Saharan Africa systematic review found that knowledge of partner’s HIV status was a determinant of PrEP awareness [33]. Moreover, PrEP is a recommended safe conception strategy in the setting of HIV sero-different partnerships [38]. In contrast to prevailing literature, we found that the odds of being PrEP aware and using PrEP prior to pregnancy were significantly lower among women whose sexual partner’s HIV status was unknown. Additionally, we found no association between current use of PrEP and having a partner with unknown status. Two qualitative studies in SA revealed, having a status unknown partner was a motivating factor for PrEP usage [20, 36]. Our findings could be attributed to low risk perception [39] or other, as yet unidentified factors, underscoring a potential area for improved counselling in ANC and other settings.

In this study, although nearly one-third of pregnant women had substantial risk for HIV infection, the prevalence of current PrEP use (6.50%) and prior PrEP use (3.58%) was low. A study conducted in Eastern Cape among adolescents and young adults aged 16–24 years found that PrEP use (ever) was 1.70% [40]. The low PrEP coverage among pregnant women in our study is supported, in part, by findings from a qualitative study on the influences of PrEP adherence– this study found that women discontinued PrEP during pregnancy due to fears of adverse consequences on the baby [21].

Study findings show that women who reported never having HIV testing prior to their current pregnancy and women who were married or cohabiting were less likely to use PrEP both prior to their pregnancy and during their pregnancy. Conversely, those who had multiple partners in the past twelve months were more likely to be on PrEP prior to pregnancy. A study among urban men who have sex with men in the United States showed that having multiple sexual partners was associated with PrEP coverage [41]. Findings among those who had never tested for HIV prior to pregnancy, those married or cohabiting and those with multiple sexual partners speak to risk perception. Research has shown higher levels of PrEP initiation among women who perceive themselves to be at risk of acquiring HIV [32, 36].

Furthermore, our study results show that first-ANC visit attendees were less likely to be currently taking PrEP. Prior research has shown that lack of awareness of PrEP availability at clinics is common [34]. There is a possibility that women presenting to ANC could be accessing HIV care and prevention services for the first time, and thus learn about their HIV status and HIV prevention resources such as PrEP at this initial ANC visit. As a recommendation, PrEP awareness and education interventions are needed to increase awareness about PrEP availability at public clinics in South Africa. Lastly, study findings show, those who tested positive for syphilis were more likely to use PrEP during current pregnancy. According to PrEP guidelines, PrEP should be offered to those at substantial risk of HIV infection, which includes those who have had an STI in the recent past [10].

Limitations to the ANC Sentinel Survey include that this survey was restricted to public health facilities and does not capture pregnant women accessing ANC at private facilities. However, our sample is representative of the general population given that the majority of pregnant women utilize public ANC services in SA [42]. Moreover, the ANC Sentinel Survey’s cross-sectional design captures pregnant women at a single point in time and cannot be followed over time to determine PrEP persistence, the HIV status of both the mother and infant at delivery, and PrEP initiation after study enrolment. In addition, our study is limited to the self-reported HIV status of the partner, therefore, there might be under-reporting, especially among women with an HIV-positive partner. Another limitation is the inclusion of HIV-negative women with HIV-positive partners as eligible for PrEP. Under the NDoH guidelines [7], this is not a PrEP priority criterion unless the partner is virally unsuppressed, unfortunately, data on partner’s viral suppression was not available. However, it is important to note, women with HIV-positive partners constituted only 4% of the women designated eligible for PrEP. Lastly, our analysis is limited to pregnant women eligible for PrEP based on the NDoH guidelines. Although the eligibility criteria helped to identify those at substantial risk, PrEP is accessible to all HIV-negative people who request PrEP, including those who are not substantial risk of HIV based on the criteria. Despite the limitations, as a strength, our study consisted of a nationally representative study sample that consists of a large sample size and as such, our results can be generalizable to HIV-negative pregnant women in SA. We expect our findings to still be applicable given that only now do the PMTCT guidelines (2023) [11] recommends PrEP to be used an HIV prevention intervention for HIV-negative pregnant and breastfeeding women, and in the general population PrEP coverage is still relatively low (< 1% in 2023) [12].

Conclusion

In conclusion, PrEP awareness and coverage was low among eligible pregnant women with substantial risk for HIV acquisition. PrEP is being integrated into safe conception programs as a HIV prevention strategy. Entry into ANC presents an important opportunity to prevent new HIV infections among mothers and accelerate elimination of MTCT of HIV in the country. Educational initiatives could be considered in efforts to inform women about PrEP, PrEP availability at public clinics, and about the risk of HIV acquisition during pregnancy.

Funding

This manuscript has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of cooperative agreement number 5NU2GGH001934-05-00. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.

Footnotes

Declarations

Conflict of Interest The authors have no conflict of interest to declare.

1

§See e.g., 45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. § 241(d); 5 U.S.C. § 552a; 44 U.S.C. § 3501 et seq.

References

  • 1.UNAIDS. Country factsheets - South Africa 2022. 2022. [Google Scholar]
  • 2.Kufa T, Shangase N, Lombard C, Manda S, Puren A. The 2022 Antenatal HIV Sentinel Survey Key findings. National Department of Health; 2024. [Google Scholar]
  • 3.Woldesenbet S, Kufa-Chakezha T, Lombard C, Manda S, Cheyip M, Ayalew K, et al. Recent HIV infection among pregnant women in the 2017 antenatal sentinel cross–sectional survey, South Africa: assay–based incidence measurement. PLoS ONE. 2021;16:e0249953. 10.1371/journal.pone.0249953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Johnson LF, Meyer-Rath G, Dorrington RE, Puren A, Seathlodi T, Zuma K et al. The Effect of HIV Programs in South Africa on National HIV incidence trends, 2000–2019. JAIDS J Acquir Immune Defic Syndr 2022;90. [DOI] [PubMed] [Google Scholar]
  • 5.UNAIDS. HIV Prevention 2025 Road Map. Switzerland: 2022. [Google Scholar]
  • 6.WHO. WHO Expands Recommendation on Oral Preexposure Prophylaxis Of HIV Infection (PrEP). 2015. [Google Scholar]
  • 7.Department of Health. Updated Guidelines for the Provision Of Pre-Exposure Prophylaxis (PrEP) to Persons at Substantial Risk of HIV Infection. 2021. [Google Scholar]
  • 8.NDoH. PrEP Implementation Pack: South Africa 2016–2017. 2017. [Google Scholar]
  • 9.WHO. Technical brief: preventing HIV during pregnancy and breastfeeding in the context of PrEP. Geneva: World Health Organization; 2017. [Google Scholar]
  • 10.Department of Health. Guidelines for the Provision Of Pre-Exposure Prophylaxis (PrEP) to persons at substantial risk of HIV Infection. 2020. [Google Scholar]
  • 11.Department of Health. Guidelines for vertical transmission prevention of communicable infections. Pretoria, South Africa: 2023. [Google Scholar]
  • 12.Johnson LF, Dorrington RE. Modelling the impact of HIV in South Africa’s provinces: 2024 update. South Africa: 2024. [Google Scholar]
  • 13.AVAC. South Africa - PrEP. PrEP Watch n.d https://www.prepwatch.org/country/south-africa/ [Google Scholar]
  • 14.Donnell D, Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, et al. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study. Lancet HIV. 2021;8:e495–501. 10.1016/S2352-3018(21)00048-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Beesham I, Milford C, Smit J, Joseph Davey DL, Baeten JM, Heffron R, et al. Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa. BMC Public Health. 2023;23:1210. 10.1186/s12889-023-16139-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Muhumuza R, Ssemata AS, Kakande A, Ahmed N, Atujuna M, Nomvuyo M, et al. Exploring perceived barriers and facilitators of PrEP uptake among young people in Uganda, Zimbabwe, and South Africa. Arch Sex Behav 2021;50:1729–42. 10.1007/s10508-020-01880-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ntinga X, Isehunwa OO, Msimango LI, Smith PM, Matthews LT, Van Heerden A. Perceptions of pre-exposure Prophylaxis (PrEP) for HIV prevention among men living with HIV in the context of reproductive goals in South Africa: a qualitative study. BMC Public Health. 2024;24:553. 10.1186/s12889-024-18118-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Shamu S, Shamu P, Khupakonke S, Farirai T, Chidarikire T, Guloba G, et al. Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts. Glob Health Action. 2021;14:1886455. 10.1080/16549716.2021.1886455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mapetla K, Mokgatle M, Oguntibeju O. Barriers and facilitators influencing the uptake and acceptability of HIV pre-exposure prophylaxis amongst commercial female sex workers in Tshwane district, Gauteng province: a descriptive study. Int J Innov Res Sci Stud 2023;7:753–61. 10.53894/ijirss.v6i4.1952. [DOI] [Google Scholar]
  • 20.Joseph Davey DL, Knight L, Markt-Maloney J, Tsawe N, Gomba Y, Mashele N, et al. I had made the decision, and no one was going to stop me —Facilitators of PrEP adherence during pregnancy and Postpartum in Cape Town, South Africa. AIDS Behav 2021;25:3978–86. 10.1007/s10461-021-03320-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wyatt MA, Pisarski EE, Kriel Y, Smith PM, Mathenjwa M, Jaggernath M, et al. Influences on PrEP uptake and adherence among South African women during periconception and pregnancy: a qualitative analysis. AIDS Behav 2023;27:208–17. 10.1007/s10461-022-03757-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.SANAC. National Strategic Plan for HIV. STIs: TB; 2023. pp. 2023–8. [Google Scholar]
  • 23.Woldesenbet SA, Lombard C, Manda S, Kufa T, Ayalew K, Cheyip M, et al. The 2019 National Antenatal HIV Sentinel Survey (ANCHSS) Key findings. National Department of Health; 2021. [Google Scholar]
  • 24.National Department of Health. Basic antenatal care plus hand-book second edition. 2017. [Google Scholar]
  • 25.National Department of Health. Sexually transmitted infections Management Guidelines 2018. National Department of Health; 2018. [Google Scholar]
  • 26.Torres TS, Luz PM, De Boni RB, de Vasconcellos MTL, Hoagland B, Garner A, et al. Factors associated with PrEP awareness according to age and willingness to use HIV prevention technologies: the 2017 online survey among MSM in Brazil*. AIDS Care. 2019;31:1193–202. 10.1080/09540121.2019.1619665. [DOI] [PubMed] [Google Scholar]
  • 27.Bunting SR, Garber SS, Goldstein RH, Ritchie TD, Batteson TJ, Keyes TJ. Student Education about pre-exposure Prophylaxis (PrEP) varies between regions of the United States. J Gen Intern Med 2020;35:2873–81. 10.1007/s11606-020-05736-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ssuna B, Katahoire A, Armstrong-Hough M, Kalibbala D, Kalyango JN, Kiweewa FM. Factors associated with willingness to use oral pre-exposure prophylaxis (PrEP) in a fisher-folk community in peri-urban Kampala, Uganda. BMC Public Health. 2022;22:468. 10.1186/s12889-022-12859-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Siegler AJ, Bratcher A, Weiss KM. Geographic Access to Preexposure Prophylaxis Clinics among men who have sex with men in the United States. Am J Public Health. 2019;109:1216–23. 10.2105/AJPH.2019.305172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Woldesenbet SA, Kufa T, Barron P, Chirombo BC, Cheyip M, Ayalew K et al. Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa. AIDS. 2020;34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.DiTullio DJ, Farley E, Gomba Y, Coates TJ, Bekker L-G, Myer L, et al. Factors associated with knowledge of pre-exposure prophylaxis in pregnant women in Cape Town, South Africa. Int J STD AIDS. 2019;30:1063–70. 10.1177/0956462419863216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Beesham I, Heffron R, Evans S, Baeten JM, Smit J, Beksinska M, et al. Exploring the use of oral pre-exposure Prophylaxis (PrEP) among women from Durban, South Africa as Part of the HIV prevention Package in a clinical trial. AIDS Behav 2021;25:1112–9. 10.1007/s10461-020-03072-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Nagai H, Ankomah A, Fuseini K, Adiibokah E, Semahegn A, Tagoe H. HIV pre-exposure prophylaxis uptake among high-risk population in Sub-saharan Africa: a systematic review and meta-analysis. AIDS Patient Care STDs. 2024;38:70–81. 10.1089/apc.2023.0117. [DOI] [PubMed] [Google Scholar]
  • 34.Haffejee F, Fasanmi-Kana O, Ally F, Thandar Y, Basdav J. Four years later: do South africans know what pre-exposure prophylaxis for HIV is? AIDS Care. 2023;35:466–73. 10.1080/09540121.2022.2032573. [DOI] [PubMed] [Google Scholar]
  • 35.Terefe B, Jembere MM, Asgedom DK, Lakew AM. Knowledge and attitude to HIV pre exposure prophylaxis among women in five sub-saharan African countries: a multilevel model analysis of population-based survey 2021–2022. BMC Public Health. 2024;24:1253. 10.1186/s12889-024-18717-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, et al. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PLoS ONE. 2020;15:e0228620. 10.1371/journal.pone.0228620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ogolla M, Nyabiage OL, Musingila P, Gachau S, Odero TMA, Odoyo-June E, et al. Uptake and continuation of HIV pre-exposure prophylaxis among women of reproductive age in two health facilities in Kisumu County, Kenya. J Int AIDS Soc 2023;26:e26069. 10.1002/jia2.26069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Heffron R, Pintye J, Matthews LT, Weber S, Mugo N. PrEP as peri-conception HIV Prevention for women and men. Curr HIV/AIDS Rep 2016;13:131–9. 10.1007/s11904-016-0312-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Joseph Davey D, Farley E, Towriss C, Gomba Y, Bekker L-G, Gorbach P, et al. Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: programmatic implications for PrEP delivery. PLoS ONE. 2018;13:e0197143. 10.1371/journal.pone.0197143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ajayi AI, Mudefi E, Yusuf MS, Adeniyi OV, Rala N, Goon DT. Low awareness and use of pre-exposure prophylaxis among adolescents and young adults in high HIV and sexual violence prevalence settings. Med (Baltim). 2019;98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Morgan E, Moran K, Ryan DT, Mustanski B, Newcomb ME. Threefold increase in PrEP Uptake Over Time with High Adherence among Young men who have sex with men in Chicago. AIDS Behav 2018;22:3637–44. 10.1007/s10461-018-2122-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Statistics South Africa. Maternal health indicators: further analysis of the 1998 and 2016 South Africa demographic and health surveys. 2020. [Google Scholar]

RESOURCES